James E. Voss
- Virology top 1%
- HIV Research and Treatment 12
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research 3
- Immunology top 10%
- Immune Cell Function and Interaction 4
- T-cell and B-cell Immunology 3
-
- Monoclonal and Polyclonal Antibodies Research 5
-
- CRISPR and Genetic Engineering 4
- Glycosylation and Glycoproteins Research 2
-
- CAR-T cell therapy research 3
James E. Voss
22 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 74
- Virology 477
- Infectious Diseases 697
- Public Health, Environmental and Occupational Health 630
- Immunology 306
- Radiology, Nuclear Medicine and Imaging 195
Countries citing papers authored by James E. Voss
This map shows the geographic impact of James E. Voss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Voss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Voss more than expected).
Fields of papers citing papers by James E. Voss
This network shows the impact of papers produced by James E. Voss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Voss. The network helps show where James E. Voss may publish in the future.
Co-authorship network
The 25 scholars most cited alongside James E. Voss, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 24 | |
| 2 | 2022 | 52 | |
| 3 | 2021 | 5 | |
| 4 | 2021 | 8 | |
| 5 | 2020 | 50 | |
| 6 | 2020 | 52 | |
| 7 | 2020 | 12 | |
| 8 | 2019 | 1 | |
| 9 | 2019 | 63 | |
| 10 | 2017 | 42 | |
| 11 | 2017 | 39 | |
| 12 | 2016 | 10 | |
| 13 | 2016 | 140 | |
| 14 | 2016 | 5 | |
| 15 | 2015 | 116 | |
| 16 | 2015 | 23 | |
| 17 | 2013 | 3 | |
| 18 | 2011 | 230 | |
| 19 | 2011 | 14 | |
| 20 | Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallographybreakdown → | 2010 | 507 |
About James E. Voss
James E. Voss is a scholar working on Virology, Infectious Diseases and Immunology, having authored 22 papers that have together received 1.4k indexed citations. Recurring topics across this work include HIV Research and Treatment (12 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Immune Cell Function and Interaction (4 papers), CRISPR and Genetic Engineering (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), CAR-T cell therapy research (3 papers), T-cell and B-cell Immunology (3 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Virology (477 citations), Infectious Diseases (697 citations) and Public Health, Environmental and Occupational Health (630 citations). James E. Voss has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include F.A. Rey, Andrew Thompson, Elodie Crublet, M.C. Vaney, Christine Girard-Blanc, G. Bricogne, Clemens Vonrhein, S. Duquerroy, Dennis R. Burton and Bryan Briney. Their work appears in journals such as The Journal of Immunology, Nature Communications, Cell Reports, Immunity and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.